Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.

Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.
复制标题

DOI:
10.1111/cas.13788
复制
发表时间:
2018-11
期刊:
影响因子:
5.7
通讯作者:
Deng H
Deng H
中科院分区:
医学2区
文献类型:
--
作者:
Liu L;Liu Y;Liu X;Zhang N;Mao G;Zeng Q;Yin M;Song D;Deng H

文献摘要

参考文献

被引文献

相似文献

Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inhibited the viability and induces caspase‐dependent apoptosis in human pancreatic cancer cells Panc‐1 and Aspc. Resibufogenin‐induced apoptosis was through inhibition of constitutive nuclear factor‐κB (NF‐κB) activity and its target genes’ expression, which was caused by downregulation of transforming growth factor‐β‐activated kinase 1 (TAK1) levels and suppression of IκB kinase activity in Panc‐1 and Aspc cells. This induction of TAK1‐mediated NF‐κB inactivation by RB was associated with increased glycogen synthase kinase‐3 (GSK‐3) phosphorylation and subsequent suppression of its activity. Moreover, RB‐induced GSK‐3 phosphorylation/inactivation acted through activation of protein kinase C but not Akt. Finally, RB suppressed human pancreatic tumor xenograft growth in athymic nude mice. Thus, our findings reveal a novel mechanism by which RB suppresses TAK1‐mediated NF‐κB activity through protein kinase C‐dependent inhibition of GSK‐3. Our findings provide a rationale for the potential application of RB in pancreatic cancer therapy.
DOI: 10.1016/j.jbior.2013.09.013
发表时间: 2014-01-01
影响因子: --
作者:
McCubrey, James A.;Davis, Nicole M.;Steelman, Linda S.
通讯作者: Steelman, Linda S.
DOI: 10.1111/cas.13028
发表时间: 2016-10
期刊: Cancer science
影响因子: 5.7
作者:
Domoto T;Pyko IV;Furuta T;Miyashita K;Uehara M;Shimasaki T;Nakada M;Minamoto T
通讯作者: Minamoto T
DOI: 10.1371/journal.pone.0129851
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
Ichikawa M;Sowa Y;Iizumi Y;Aono Y;Sakai T
通讯作者: Sakai T
DOI: 10.1093/jnci/djr243
发表时间: 2011-08-01
影响因子: 10.3
作者:
Melisi, Davide;Xia, Qianghua;Chiao, Paul J.
通讯作者: Chiao, Paul J.
DOI: 10.1016/j.yexcr.2012.08.008
发表时间: 2012-12-10
影响因子: 3.7
作者:
Deng, Hongbin;Zhang, Na;Li, Diandong
通讯作者: Li, Diandong